Request Demo
Last update 23 Jan 2025
Zhejiang Yizeda Pharmaceutical Technology Co., Ltd.
Private Company|
2022|
Zhejiang Sheng, China
Last update 23 Jan 2025
Overview
Tags
Otorhinolaryngologic Diseases
Nervous System Diseases
Immune System Diseases
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20234251
米格列奈钙片随机、开放、交叉设计在中国健康受试者中的生物等效性正式试验
[Translation] A randomized, open-label, crossover design formal bioequivalence trial of mitiglinide calcium tablets in Chinese healthy subjects
CTR20240275
随机、开放、单剂量、两制剂、交叉对照设计，评价空腹及餐后状态下单次口服受试制剂阿司匹林肠溶片与参比制剂阿司匹林肠溶片（商品名：Bayaspirin®/拜阿司匹灵®）在中国健康受试者中的生物等效性正式试验
[Translation] A randomized, open-label, single-dose, two-formulation, crossover controlled study was conducted to evaluate the bioequivalence of a single oral dose of the test formulation of enteric-coated aspirin tablets and the reference formulation of enteric-coated aspirin tablets (trade name: Bayaspirin®/Bayaspirin®) in healthy Chinese subjects.
CTR20232529
随机、开放、单剂量、两制剂、交叉对照设计，评价空腹及餐后状态下单次口服受试制剂阿司匹林肠溶片与参比制剂阿司匹林肠溶片（商品名：Bayaspirin®/拜阿司匹灵®）在中国健康受试者中的生物等效性正式试验
[Translation] A formal trial of randomized, open-label, single-dose, two-formulation, crossover design to evaluate the bioequivalence of a single oral dose of the test formulation enteric-coated aspirin tablets and the reference formulation enteric-coated aspirin tablets (trade name: Bayaspirin®/Bayaspirin®) in healthy Chinese subjects under fasting and fed conditions
100 Clinical Results associated with Zhejiang Yizeda Pharmaceutical Technology Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Zhejiang Yizeda Pharmaceutical Technology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Zhejiang Yizeda Pharmaceutical Technology Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 31 Jan 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free